Risk of second primary cancer from proton arc therapy of pediatric brain tumors

Proton arc therapy (PAT) is currently explored for clinical implementation, despite its associated low-dose bath. This study therefore aimed at evaluating the risk of radiation-induced second primary cancer (SPC) for PAT in pediatric brain tumor patients. Two brain-specific models for SPC induction...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussaint, Laura, Indelicato, Daniel J, Muren, Ludvig P, Stokkevåg, Camilla H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465935/
https://www.ncbi.nlm.nih.gov/pubmed/37655121
http://dx.doi.org/10.1016/j.phro.2023.100480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465935/
https://www.ncbi.nlm.nih.gov/pubmed/37655121
http://dx.doi.org/10.1016/j.phro.2023.100480

Ejemplares similares